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A B S T R A C T
In forensic genetics mitochondrial DNA (mtDNA) is usually analyzed by direct Sanger-type sequencing
(STS). This method is known to be laborious and sometimes prone to human error. Alternative methods
have been proposed that lead to faster results. Among these are methods that involve mass-
spectrometry resulting in base composition proﬁles that are, by deﬁnition, less informative than the full
nucleotide sequence. Here, we applied a highly automated electrospray ionization mass spectrometry
(ESI-MS) system (PLEX-ID) to an mtDNA population study to compare its performance with respect to
throughput and concordance to STS. We found that the loss of information power was relatively low
compared to the gain in speed and analytical standardization. The detection of point and length
heteroplasmy turned out to be roughly comparable between the technologies with some individual
differences related to the processes. We conﬁrm that ESI-MS provides a valuable platform for analyzing
mtDNA variation that can also be applied in the forensic context.
 2013  The Authors. Published by Elsevier Ireland Ltd.  
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Sanger-type sequencing (STS) has been the state of the art
method for analyzing the mitochondrial DNA (mtDNA) control
region (CR) in forensic genetics. Some alternative approaches have
been introduced, such as single base extension assays [1],
hybridization methods [2] and pyrosequencing [3]. It has also
been shown that electrospray-ionization mass spectrometry (ESI-
MS) can be successfully applied to analyze mtDNA variation in the
forensic context [4]. Hall et al. [5] performed these experiments
with an instrumental set-up that is highly automated and provided
customized analysis software that is missing in other approaches
especially those that use STS-based technology. This is the reason
for numerous earlier error reports criticizing the quality of mtDNA
work, not only in the forensic but general scientiﬁc ﬁeld [6].* Corresponding author at: Institute of Legal Medicine, Innsbruck Medical
University, Innsbruck, Austria. Tel.: +43 512 9003 70640; fax: +43 512 9003 73640.
E-mail address: walther.parson@i-med.ac.at (W. Parson).
1872-4973  2013 The Authors. Published by Elsevier Ireland Ltd. 
http://dx.doi.org/10.1016/j.fsigen.2013.05.007
Open access under CC BAdvancements have been made since then to improve the
production of high quality mtDNA data [7]. The main sources of
error were found in human transcription, mix-up of samples and
low-quality sequencing raw data [8,9] that could be avoided by an
automated and customized software-controlled process. The
PLEX-ID system (Abbott Laboratories, Abbott Park, IL, USA) was
designed with such features in mind and was employed here to
perform a side-by-side comparison with STS data from a
population study of South Germany (Munich). Population data
were derived from both technologies and discussed in the forensic
context with special attention to concordance and the detection of
point and length heteroplasmy.
2. Materials and methods
2.1. Samples and DNA extraction
For this study 200 blood samples were taken post-mortem in
the course of routine autopsies at the Institute of Legal Medicine,
University of Munich, from individuals originating from Munich,
Germany in agreement with the ethics commission of the
University of Munich. DNA was extracted using the Qiagen
BioRobot M48 Robotic Workstation (Qiagen, Hilden, Germany)Y-NC-SA license.
M. Eduardoff et al. / Forensic Science International: Genetics 7 (2013) 587–592588following the manufacturer’s protocol. Samples were anonymized
prior to the analysis so that no link to the donor can be established.
2.2. Ampliﬁcation and Sanger-type sequencing
Ampliﬁcation and Sanger-type sequencing were performed
according to the EMPOP protocol updated in [10]. Sequencing raw
data were interpreted independently by three different scientists
using Sequencher v4.10 and v5.0 (Gene Codes Corporation, Ann
Arbor, MI, USA). Haplotypes are provided for forensic searches
under the accession number EMP00482 in the EMPOP database
(www.empop.org; [7]).
2.3. Ampliﬁcation and mass spectrometric analysis
ESI-MS analysis was performed on the same DNA extracts
using the PLEX-ID instrument and the PLEX-ID mtDNA assay v2.0
(Abbott Laboratories, Abbott Park, IL, USA) following the
manufacturer’s recommendations. This process was highly
automated and required only minimal hands-on interaction by
the operator. In brief, the DNA extracts (1.5 ml tubes) and sealed
96-well plates including the ready-to-use PCR master-mix were
placed onto an automated liquid handling device (Tecan Trading
AG, Switzerland) and pipetting was performed with a customized
software script. PCR for each sample was set up in eight
independent wells (one column of a 96-well plate) with a total
of 24 primer pairs. The amplicons were designed to cover the
entire mtDNA CR from nucleotide position (ntp) 15,924–576 in an
overlapping manner with the exception of nucleotide positions
(ntps) 16,251–16,253 and 16,428–31 that were not targeted by
the approach. Plates were resealed after pipetting using a variable
temperature sealer (Integrated Technologies Ltd., Kent, UK) and
PCR was performed on an Eppendorf Mastercyclers Pro S
(Eppendorf, Hamburg, Germany) with an initial denaturation
temperature of 95 8C for 10 min, 36 cycles of 95 8C for 20 s, 50 8C
for 90 s (5% ramp speed), and 72 8C for 5 s, followed by 72 8C for
4 min, 99 8C for 10 min and a ﬁnal hold at 4 8C. The 96-well plates
including the ampliﬁcation products were then directly loaded
onto the PLEX-ID instrument and the run was started. On the
PLEX-ID the plate was ﬁrst directed to an automated sample
puriﬁcation using magnetic beads and then amplicons were
automatically subjected to electrospray ionization time-of-ﬂight
mass spectrometry following the principle described earlier [5].
Negative and positive controls were carried through the entire
analytical process. After the run, raw data were automatically
analyzed using the software package IbisTrack using default
settings (Ibis Biosciences, Inc., Carlsbad, CA) to calculate and
interpret the resulting base composition proﬁles (BCPs).
A full BCP of a sample consisted of the array of all base
compositions (BCs) resulting from each of the analyzed amplicons.
A single point heteroplasmy (PHP) in an ampliﬁed region was
called, when two amplicons were generated by the same primer
pair and gave identical total nucleotide counts (i.e. lengths), but
differed by a single base state in their deduced base compositions
(e.g. PHP in the region ampliﬁed by PP2897: 15A 8G 15C 14T; 15A
8G 14C 15T). Length heteroplasmy (LHP) was identiﬁed as two or
more BCs resulting from amplicons of a single primer pair with
different nucleotide counts (e.g. PP2908: A42 G16 C39 T32; A42
G16 C40 T32).
2.4. Comparison of STS and ESI-MS derived haplotypes
ESI-MS-derived BCPs were exported into Extensible Markup
Language (XML) format for data handling and interpretation with
the software package R (version 2.14.1 (2011-12-22) on Platform:
i386-pcmingw32/i386 (32-bit) [19]). Each XML BCP was convertedinto a list object in R. Its abundance measurement was parsed from
the data ﬁles generated by the IbisTrack software and stored thereto.
Sanger-type sequences were converted into FASTA format.
BCPs were calculated in R by counting the number of A, T, G and
Cs contained in mtDNA regions identical in range to the PLEX-ID
amplicons (disregarding primer sequences). PHP was called
using IUPAC code and for each variant an individual BCP was
determined. Samples with length heteroplasmic C-stretches
were called by the dominant (most abundant) variant using
non-repetitive bases as reference as described in [11] and
therefore yielded a single BCP for the corresponding primer pair.
Peak height ratios for PHP detected by STS were determined
manually and classiﬁed into three categories, low level (<20%),
20–80% and >80%, taking into consideration that STS with dye
terminators is not always displaying mixture ratios correctly. For
all computational analysis steps involving BCPs only forward
strands were used.
3. Results and discussion
3.1. Overall performance, success rate and analyzed regions
A total of 200 DNA extracts were subjected to STS and ESI-MS
analysis. The PLEX-ID workﬂow for the analysis of the mtDNA CR
was highly automated, standardized and fully supported by
software including the analysis of the resulting BCPs of the
analyzed PCR amplicons. The analysis of the 200 samples took a
total of six working days, including a quick review of the
individual chromatograms and the repetition of 18 samples that
failed to give a full BCP at ﬁrst attempt. The PLEX-ID setup
outperformed manual STS by an experienced mtDNA sequencing
laboratory, in which the analysis of the same sample set took 10
working days for wet-lab analysis and a total of 120 h for data
interpretation.
Among the repeated samples in the PLEX-ID approach were 15
where three or less amplicons dropped out. Most often primer
pairs 2893 and 2908 covering the homopolymeric C-stretches
were affected. One sample (MUC089) yielded no results with both
technologies due to insufﬁcient amount of mtDNA and was
therefore excluded from the study. Another sample (MUC093)
gave a successful STS haplotype (16126C 16129A 16294T 16296T
16304C 16519C 73G 263G 315.1C 315.2C, Table S1), but resulted
in only a partial BCP using the PLEX-ID (data not shown), even
after repetition. For this sample, three amplicons (produced by
primer pairs 2907, 2908 and 2923, Fig. S1) covering the C-stretch
in hypervariable segment II (HVS-II) did not yield useful results.
Two primers showed mismatches with respect to the STS
haplotypes. The reverse primer 2908R mismatched at positions
315.1C 315.2C (insertions) and 330 (A/G, 50-end), whereas
forward primer 2923F mismatched at position 262 (C/T, 50-
end). PLEX-ID analysis of two similar samples outside this study
that also harbored 315.1C 315.2C led to similar dropouts of
amplicons 2908 and 2907 in both samples conﬁrming our earlier
observation, while 2923 gave a signal in one sample (data not
shown). These results suggest that the ampliﬁcation of this
particular sequence motif – that is observed in 0.2% of all samples
in EMPOP Release 9 ([7]; N = 28,518) – was suppressed. Sample
MUC093 was therefore excluded from further comparative
analysis between the two technologies.
The STS protocol covered the entire CR from ntps 16,024 to 576
(1122 base pairs for the rCRS haplotype). The PLEX-ID assay
targeted 1049 bases of the CR covering all three hypervariable
segments. The ﬁrst hypervariable segment (HVS-I) was covered by
ntps 15,924–16,428, excluding ntps 16,251–16,253. Those three
positions seem conserved in the CR, only two out of 29,444
haplotypes (EMPOP R9) showed variation here (at ntp 16,252). The
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covered by ntps 31–576 (Fig. S1).
3.2. Concordance study - direct comparison of STS and ESI-MS derived
BCPs
The STS haplotypes were computationally transformed into
BCPs and compared pair-wise with the corresponding BCPs from
the PLEX-ID approach. For this purpose a common reading frame
was set to 16,024–16,482 (excluding ntps 16,251–16,253) and 31–
576 representing the maximum overlapping coverage of both
assays. Two proﬁles deriving from a sample were considered
concordant when BCPs calculated from the comparable range
products were identical. For this purpose point and length
heteroplasmy were not considered. They are discussed in detail
later. This comparison led to concordant results conﬁrming the
expectation that mass-spectrometric BCPs match the correspond-
ing sequence derived haplotypes (turned into BCPs). Such
experiments and results serve as independent validation criterion
for ESI-MS based mtDNA analyses.
3.3. Population study
A total of 188 (94.9%) distinct STS haplotypes were observed
in the set of 198 samples of which 178 (89.8%) were unique
(Table 1). When adjusted to the PLEX-ID range (excluding ntps
15,924–16,023) 185 (93.4%) STS haplotypes were distinct in the
dataset with 173 (87.4%) singletons. With PLEX-ID 182 (91.9%)
distinct haplotypes were detected, 171 (86.4%) of which were
observed only once. We note that LHP was not considered as
exclusion. Thus, only 3 (1.5%) samples could not be further
discriminated with the MS-based method compared to STS. The
corresponding statistical values can be found in Table 1. The
relatively small loss in discrimination power put the PLEX-ID
system at an advantage over STS in the light of gaining
automation and reducing analysis time of BCPs.
In our sample set seven of the 24 PLEX-ID amplicons did not
show variation, whereas the remaining amplicons included
sequence or length variants (Fig. S2A). The most conserved regions
were covered by primer pairs 2925, 2899, 2910 and 2916, which
showed less than three variants in this sample set (Fig. S2B). The
distribution of variants across amplicons seemed to indicate that
most samples differed by one or two variants whereas the
remaining variants were detected in few samples only (Fig. S2C).
These data conﬁrm earlier ﬁndings of high discrimination power of
ESI-MS based systems in the CR [12].
3.4. Point heteroplasmy (PHP)
PHP is known as the detectable coexistence of two (rarely
more) sequences that differ usually at only one position in the
mtGenome [13]. It has been shown that the sensitivity of
detecting PHP, or mixtures in general, is correlated with the
technology and it seems that the abundance of PHP is positively
correlated with sensitivity of detection [14]. STS using Dye
Terminator sequencing chemistry is known to display a particularTable 1
Comparing population statistics for STS and PLEX-ID derived haplotypes.
Full STS 16,024–576 Adjus
No. of samples 198 198 
No. of haplotypes 188 185 
No. of unique haplotypes 178 173 
Random match probability 0.006 0.0
Haplotype diversity 0.994 0.9
Power of discrimination 99.424 99.3PHP at varying peak height ratios depending on the position
affected and primer used. Hence, in some cases peak height ratios
do not correspond with the relative amount of the contributing
sequence variants. For the purpose of this study, PHP was called in
STS data when redundant sequences provided clear evidence of
the presence of a mixture with respect to signal-to-noise ratios. In
contrast, ESI-MS produces discernable signals for PHP variants
(due to mass differences) and their mass peak heights are
quantitatively correlated with the amount of contributing
variants [15].
With STS 14 (7.1%) PHPs were called in 14 of 198 samples
(Table 2, S1 and S2). The PLEX-ID assay detected 19 (9.6%) PHPs in
17 (8.6%) of these 198 samples, 11 of which were matching those
found in STS.
Due to the overlapping design of amplicons PHP was detected
multiple times in the PLEX-ID assay, if located in a region covered
by more than one primer pair. Here we discern PHPs that were
present in all corresponding BCPs (full detection) from those that
were displayed only in some (partial detection). In this sample set
four (2%) PHPs were detected only partially in the ESI-MS data
(Table S3: MUC045, MUC118, MUC169, MUC172) and two were
not detected at ﬁrst analysis at all (Table S3: MUC049, MUC059,
MUC094 and Fig. S3) compared to STS data. The reasons for this
were threefold. In samples MUC049, MUC045, MUC118, MUC172,
and MUC059 one of the mass peaks was masked by salt adducts, in
sample MUC169 one of the mass peaks was below the detection
level and in sample MUC094 PHP was positioned in a region that
also showed length heteroplasmy with three length variants,
which is why the PHP variants were most probably ‘‘diluted’’ below
detection level (Fig. S4).
With the PLEX-ID assay, seven PHPs were called that were
primarily not identiﬁed with STS. One of these was found at
position 16022 that resided outside the reported region for STS, but
could be conﬁrmed in the raw data (primer F15851, MUC013).
Three PHPs were detected at low levels (<20%) (Fig. S5), and three
remained undetected with STS even after review. MUC169 was the
only sample showing mixed bases at three positions, two of which
were detected only with PLEX-ID (Table S4).
After review of both datasets, 17 PHPs were detected in common
between the two approaches. The major variants (dominant types)
were concordant except for PHP at ntp 204 (Y) in sample MUC194,
which showed opposite but almost equally high peak ratios in the
two assays. In the other instances peak height ratios were
comparable between the technologies (Table S5).
PHPs were most frequently observed in amplicons produced by
PP2897 and PP2898, both including ntp 16,093 (Fig. 1), which was
also found to be the CR hotspot for PHP occurrence in a much larger
systematic STS study [13]. In further accordance with this
reference our sample set showed PHPs in fragments produced
by PP2904, PP2905 and PP2906, which included positions 146, 152,
195, 204 and 215. These particular sites are known for showing a
higher PHP frequency.
The samples analyzed in this study showed PHP at expected
positions. Also their frequency in STS data (7.1%) conﬁrmed other
studies ([13] and references therein). ESI-MS conﬁrmed PHPs








Summary of PHPs found with STS and PLEX-ID typing. Number in parenthesis refer to PHP in the same coverage range.
STS PHPs PLEX-ID PHPs Common PHPs PLEX-ID PHPs reanalysis STS PHPs reanalysis Common PHPs reanalysis
Total # of samples 198 198 198 198 198 198
# of samples with PHPs 14 17 (16) 11 18 (17) 17 16
PHPs 14 19 (18) 11 20 (19) 17 16
% PHPs 7.1 9.6 (9.1) 5.5 10.1 (9.5)a 8.6a 8.1
a Not statistically signiﬁcant at a = 0.05.
Fig. 1. Distribution of PHPs across the 24 amplicons targeted by the PLEX-ID assay, ordered 50–30 according to control region coordinates.
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by STS. Excluding contamination the PLEX-ID based detection of
PHP seems at least as sensitive as STS, in some instances even more
sensitive. This has also been found in other studies [12] and seems
to relate to the decreased sensitivity level of mixture detection in
STS with Dye Terminator sequencing chemistry.
3.5. Length heteroplasmy (LHP)
LHP is more frequently encountered in the mtDNA CR than PHP
and refers to the presence of multiple length variants in a single
donor sample. Homopolymeric C-tracts are prone to LHP when
more than 8 residues of a nucleotide are present in an
uninterrupted stretch, e.g. around ntps 16,189, 310, and 573 in
the CR [16]. The mechanisms are poorly understood and likely
involve strand slippage phenomena introduced by the polymerase.
Also other regions show LHP, such as the dimeric repeat region
between positions 513 and 524, the T-tract between positions 451
and 456 and random positions when mixtures with indels are
present. Most of the LHPs are instable between maternal members
of a pedigree and even between tissues of an individual [16] and
therefore not regarded as exclusive evidence in forensic mtDNA
testing. It has been reported that the detection of LHP varies with
respect to ampliﬁcation and sequencing parameters [17], which is
why variation in such regions either is completely disregarded or
the dominant variant is called [11].
For the purpose of comparing LHP between the two technolo-
gies applied here, LHP was also determined in STS data by countingTable 3
Summary of LHP found with PLEX-ID and STS. Numbers in brackets indicate numbers 
STS PLEX-ID PL
HVS-I (C-tract) 25 25 22
HVS-II (C-tract) 114 (13)a 85a 57
HVS-III (C-tract) 6 5 0
AC-Stretch 7 4 0
Total LHP 119 79
a Not statistically signiﬁcant at a = 0.05.the number of indicator bases at positions 16,196, 310 and 577 for
the three hypervariable segments, respectively. In our sample set
25 (12.6%) samples displayed LHP in the HVS-I C-tract between
positions 16,183 and 16,194 with the PLEX-ID assay (covered by
amplicons 2893, 2895, and 2896). This was fully conﬁrmed by STS
data (Table S1). The HVS-II C-stretch between positions 302 and
310, which was also covered by three amplicons (2908, 2907, and
2906), was found to display LHP in 85 samples (42.9%) with PLEX-
ID, which concurs with STS in 79 samples leaving six samples
displaying LHP in the PLEX-ID assay only. Additional 35 samples
showed LHP with the STS assay but not with PLEX-ID (Table 3),
which may be due to differences in primers, polymerases and
buffers between the technologies.
The AC dinucleotide repeat and the C-tract in HVS-III were both
covered by a single amplicon (2913) in the PLEX-ID assay. Four
samples showing LHP in the C-stretch were concordant between
STS and PLEX-ID assays, two additional samples were detected by
STS and one additional sample by the PLEX-ID assay. Differences in
AC-repeat variants were more pronounced with only one over-
lapping sample between the two assays (Tables 3 and S6).
To examine differences in dominant C-variant calling between
the two assays, all PLEX-ID BCs covering the length variation
stretches HVS-I, HVS-II and HVS-III/AC were ﬁltered for their most
abundant BC measured for each ampliﬁed fragment. Overall,
concordance was high between dominant length variant calls in
these regions. 15 BCs out of 1386 BCs (1.08%) compared were
discordant between the different assays In 11 of these BCs the
dominant (most abundant) variant called by the PLEX-ID assay wasof samples with low level (<20%) LHP.






Fig. 2. Number of samples exhibiting different numbers of length heteroplasmic variation per amplicon covering C-stretches in HVS-I (A) and HVS-II (B).
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ten of these ﬁfteen BCs, the abundance of the dominant variant
called by the PLEX-ID assay lay within 20% of the abundance of the
peak representing the STS called dominant variant. These samples
were repeated to see if the differences were consistent. One sample
could not be analyzed further as the region of interest was not
ampliﬁed in the repeat (Table S7, MUC164). For two repeated samples
(Table S7, MUC12 PP29067 and MUC045 PP2895) the concordant STS
variant was called as most abundant variant, whereas all other most
abundant BCs called by the PLEX-ID remained the same as in the ﬁrst
analysis of the samples. Interestingly, nine of these reanalyzed primer
pairs did not produce the same number of length variants as in the
ﬁrst analysis. Further studies would have to be conducted in order to
show if the reason for this is decreased system sensitivity or any other
cause for randomized LHP detection.
Finally, with the PLEX-ID assay the number of LHP variants was
more heterogeneous in the HVS-I C-stretch (1–5) compared to the
HVS-II C-stretch (2–4), which is concordant with STS data and
previous ﬁndings using fragment size analysis [11] (Fig. 2).
4. Conclusions
The PLEX-ID system has been described and evaluated
previously as a reliable and useful tool for mtDNA analysis [18].
In this study, these results were conﬁrmed in terms of concor-
dance of the data generated by the mtDNA Assay v2.0 on the PLEX-
ID platform with STS data. Furthermore, this study shows that
using PLEX-ID BCPs for population statistics is not only viable, but
only results in a 1.5% loss of resolution compared to conventional
STS analysis. This loss is counterbalanced by the high degree of
automation of the system, encompassing shorter analysis time
and sample traceability, as well as the potential for high
throughput analysis. In terms of point heteroplasmy detection,
the PLEX-ID system seems slightly more sensitive than conven-
tional STS analysis, bearing in mind that automated detection
levels are highly dependent on software settings in the PLEX-ID
assay. LHP detection can be described as highly concordant in
HVS-I, with more pronounced differences in HVS-II length variant
detection, with the PLEX-ID system detecting less LHP variation in
this region. Concordance of dominant variants called in both
assays was high. Overall, the PLEX-ID mtDNA CR typing system
has the potential to be an equivalent alternative to STS, offering a
cost and time reducing, ease-of-use, standardized, automated
sample preparation and analysis. The PLEX-ID instrument and
chemistry are no longer commercially available and the service for
forensic genetics has been discontinued. However, this does not
diminish the scientiﬁc concept and methodology presented in this
manuscript. On the contrary, our ﬁndings indicate the usefulnessof MS-based applications for mitochondrial forensics and
continue to support its utility.
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